Paul Sekhri is an experienced leader in the pharmaceutical and biotechnology sectors, currently serving as Chairman, President, and CEO of vTv Therapeutics, Inc. since August 2022. Sekhri holds multiple board positions, including memberships at AdhereTech, ORYN Therapeutics, Spring Discovery, Longboard Pharmaceuticals, and Veeva Systems. Previous leadership roles include Chairman of the Board at Compugen Ltd. and Pharming Group N.V., as well as involvement in the audit and innovation committees at Ipsen. Sekhri's educational background includes a Bachelor's degree in Zoology from the University of Maryland and the University of Maryland School of Medicine.
Sign up to view 0 direct reports
Get started